title: Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas.
abstract: BACKGROUND
  Non-melanoma skin cancers are one of the most common human malignancies accounting for 2-3% of tumors in the US and represent a significant health burden. Epidemiology studies have implicated Tp53 mutations triggered by UV exposure, and human papilloma virus (HPV) infection to be significant causes of non-melanoma skin cancer. However, the relationship between Tp53 and cutaneous HPV infection is not well understood in skin cancers. In this study we assessed the association of HPV infection and Tp53 polymorphisms and mutations in lesional specimens with squamous cell carcinomas.
  
  
  METHODS
  We studied 55 cases of histologically confirmed cutaneous squamous cell carcinoma and 41 controls for the presence of HPV infection and Tp53 genotype (mutations and polymorphism).
  
  
  RESULTS
  We found an increased number of Tp53 mutations in the squamous cell carcinoma samples compared with perilesional or control samples. There was increased frequency of homozygous Tp53-72R polymorphism in cases with squamous cell carcinomas, while the Tp53-72P allele (Tp53-72R/P and Tp53-72P/P) was more frequent in normal control samples. Carcinoma samples positive for HPV showed a decreased frequency of Tp53 mutations compared to those without HPV infection. In addition, carcinoma samples with a Tp53-72P allele showed an increased incidence of Tp53 mutations in comparison carcinomas samples homozygous for Tp53-72R.
  
  
  CONCLUSIONS
  These studies suggest there are two separate pathways (HPV infection and Tp53 mutation) leading to cutaneous squamous cell carcinomas stratified by the Tp53 codon-72 polymorphism. The presence of a Tp53-72P allele is protective against cutaneous squamous cell carcinoma, and carcinoma specimens with Tp53-72P are more likely to have Tp53 mutations. In contrast Tp53-72R is a significant risk factor for cutaneous squamous cell carcinoma and is frequently associated with HPV infection instead of Tp53 mutations. Heterozygosity for Tp53-72R/P is protective against squamous cell carcinomas, possibly reflecting a requirement for both HPV infection and Tp53 mutations.
authors.affiliation: Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
authors.forename: Keith R
authors.initials: KR
authors.lastname: Loeb
authors.forename: Maryam M
authors.initials: MM
authors.lastname: Asgari
authors.forename: Stephen E
authors.initials: SE
authors.lastname: Hawes
authors.forename: Qinghua
authors.initials: Q
authors.lastname: Feng
authors.forename: Joshua E
authors.initials: JE
authors.lastname: Stern
authors.forename: Mingjun
authors.initials: M
authors.lastname: Jiang
authors.forename: Zsolt B
authors.initials: ZB
authors.lastname: Argenyi
authors.forename: Ethel-Michele
authors.initials: EM
authors.lastname: de Villiers
authors.forename: Nancy B
authors.initials: NB
authors.lastname: Kiviat
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002294:Carcinoma, Squamous Cell / Q000235:genetics* / Q000473:pathology / Q000821:virology*; D003062:Codon; D004279:DNA, Viral / Q000302:isolation & purification; D005260:Female; D005838:Genotype; D006801:Humans; D009154:Mutation; D027383:Papillomaviridae / Q000235:genetics / Q000302:isolation & purification*; D030361:Papillomavirus Infections / Q000150:complications* / Q000175:diagnosis; D011110:Polymorphism, Genetic; D012867:Skin / Q000473:pathology / Q000821:virology; D012878:Skin Neoplasms / Q000235:genetics* / Q000473:pathology / Q000821:virology*; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*
chemical_list: D003062:Codon; D004279:DNA, Viral; D016159:Tumor Suppressor Protein p53